29 results on '"Takamochi, K"'
Search Results
2. P1.24-14 Clinicopathological Characteristics of Pulmonary Squamous Cell Carcinoma with KDM5D Copy Number Loss
3. EP07.03-02 Pulmonary Ligament Approach for Robot-Assisted S9 or S9 and 10 Segmentectomy
4. P1.26-08 Usefulness and Safety of Chest Tube Removal Regardless of Drainage Volume of Pleural Effusion in Patients Who Underwent Pulmonary Resection
5. EP01.01-03 Postoperative Course of Completion Pneumonectomy May Be Better than Predicted
6. 53P Heterogeneous characteristics of KRAS mutation subtypes in surgically resected lung adenocarcinomas
7. EP02.03-025 Long-Term Oncological Outcomes and Risk Factors of Recurrence After Segmentectomy for Primary Lung Cancer
8. 1245P The role of surgery for clinical and pathological N2 lung cancer with interstitial pneumonia
9. Nrf2 expression in surgically resected lung adenocarcinomas: Its association with clinicopathologic features and driver oncogene alterations
10. P1.17-04 Multicenter Observational Study of Node-Negative Non-Small Cell Lung Cancer Patients Who Are Excluded from a Clinical Trial
11. P2.17-03 Surgical Outcomes of Repeated Anatomical Pulmonary Resection for the Ipsilateral Second Lung Cancers
12. P1.17-10 Prediction of Visceral Pleural Invasion in c-N0 Non-Small Cell Lung Cancer
13. EP1.08-02 Surgical Indication for Postoperative Regional Lymph Node Oligo-Recurrence in Non-Small Cell Lung Cancer
14. The PD-L1 expression in surgically resected lung adenocarcinoma: Its correlations with the prognosis, driver oncogene alterations and clinicopathological features
15. P3.16-25 Impact of Diabetes Mellitus on Survival Outcome in Patients with Pathological Stage IA Non-Small Cell Lung Cancer
16. Neoadjuvant chemotherapy with bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer: Survival results from a phase II feasibility study (NAVAL)
17. P3.15-28 Prognostic Nutritional Index for Predicting Postoperative Complications After Surgery Thoracic Tumor Involving the Neighboring Structures
18. P2.17-14 How Should Positive Margin for Bronchial Stumps (R1) Be Evaluated in Patients Undergoing Bronchoplasty for Lung Cancer?
19. P2.17-29 Is Collagen Vascular Disease-Associated Interstitial Lung Disease a High Risk for Lung Cancer Surgery?
20. Comprehensive analysis for immune profiles of tumor microenvironment in non-small cell lung cancers: Prognostic effect of immunomodulatory molecules
21. P3.01-71 Results of Extended Resection in T4 Non-Small Cell Lung Cancer
22. Comprehensive analysis for immune profiles of tumor microenvironment in lung adenocarcinomas: Prognostic effect of immunomodulatory molecules
23. Practical screening system of oncogenic driver fusions in lung adenocarcinoma, using the NanoString nCounter
24. Pathologic response and survival after cisplatin, pemetrexed, and bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer
25. Are the criteria indicating patients to be “medically inoperable” that are used in clinical trials on stereotactic body radiotherapy appropriate for patients with early stage non-small cell lung cancer?
26. 3014 Comprehensive analyses of oncogenic driver fusions using the NanoString nCounter in lung adenocarcinoma from Japanese never- and light-smokers
27. Proposed New Simple Criteria of Clinical Multiple Primary Lung Cancers
28. Novel Biomarkers to Discriminate Between Primary Lung Squamous Cell Carcinoma and Adenocarcinoma Identified By the Cap Analysis of Gene Expression (Cage) Method
29. Clinical predictors of pathologic N0 in peripheral adenocarcinoma of the lung
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.